Kiniksa Pharmaceuticals is a privately-held biotechnology company, focused on developing and delivering therapeutics to patients with devastating diseases and unmet medical needs. The company is developing a pipeline of programs across various stages of development. Every Second Counts!
The company has significant funding and a clear vision of building a global generational company.
Kiniksa is actively looking to acquire or in-license additional programs and technologies across all stages of development.